Executive Summary
The overnight filing batch is dominated by a broad-based Q2 FY27 earnings season that skews toward strong topline growth with mixed earnings quality: of the ten companies disclosing quarterly numbers, revenue growth ranged from ~4% (Medi Assist Q2) to 112% (Sugs Lloyd), with a median in the high-20s to low-30s, while at least six flagged margin or cash-flow strain (Schaeffler FCF -81.7% YoY, Sugs Lloyd EBITDA margin -158 bps, Quality Power gross margin -160 bps QoQ, Aarti consolidated EBITDA trailing standalone, Neogen PAT lagging EBITDA, IOL QoQ momentum stalling).
Reliance delivered its highest-ever consolidated EBITDA of Rs.62,409 Cr (+24% YoY) and PAT up 34%, but the mix was lopsided — O2C EBITDA +68-69% on tight energy markets versus Retail EBITDA down ~10-11% and PAT down 24% — a pattern echoed in Jio's 3.5% ARPU growth achieved without any tariff hike in 2.5 years. Capital allocation is a clear thread: Medi Assist announced a ~Rs.49.3 Cr buyback at Rs.425/share while Neogen completed a 6.5x oversubscribed Rs.600 Cr QIP and received a CRISIL outlook upgrade, and Quality Power's pending Rs.272 Cr WinWin acquisition remains a swing factor. Forward guidance is constructive but back-ended — Aarti's ~Rs.1,500 Cr 10-year global supply agreement starts only in FY29, Neogen's Dahej/Pakhajan phases land Feb-Mar 2027, and Prataap targets a 4-5% EBITDA margin uplift with 1.5% structural accretion in 15-18 months. The single biggest idiosyncratic positive is Juniper Green's swing to Rs.54 Cr PAT from a Rs.(18) Cr loss with an ICRA upgrade to AA-/A1+, offset by Net Debt/Net Worth of 2.22x. Near-term catalysts cluster on November 5, 2026, when Super Spinning, Thirumalai Chemicals and Banas Finance all report Q2 numbers.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Corporate governance · Company update
Tracking the trend? Catch up on the prior India Pre-Market Regulatory Roundup digest from November 01, 2026.
Investment Signals (12)
- Reliance Industries ↓ (BULLISH)▲
Consolidated EBITDA hit a record Rs.62,409 Cr (+24% YoY) with PAT up 34% to ~Rs.30,000 Cr, powered by O2C EBITDA of Rs.25,203 Cr (+68-69% YoY) on exceptionally tight energy markets — the strongest absolute earnings print in the batch
- Juniper Green Energy ↓ (BULLISH)▲
PAT swung to Rs.54 Cr from Rs.(18) Cr YoY, EBITDA up 2.6x to Rs.340 Cr at 91% margin, capacity at 2,844 MWp + 604 MWh BESS with 1,036 MWp commissioned in FY27 to date, and ICRA upgraded to AA- (Stable)/A1+
- Quality Power Electrical Equipments ↓ (BULLISH)▲
Q2 PAT +80.1% YoY to Rs.63.33 Cr on Total Income +34.1% to Rs.285.45 Cr, EBITDA margin expanded 610 bps to 28.6%, with a Rs.2,010 Cr order book and new Sangli coil factory plus Turkey PCS manufacturing now live
- Neogen Chemicals ↓ (BULLISH)▲
Revenue +42% YoY to Rs.296 Cr, EBITDA +51% to Rs.45.3 Cr, PAT +144% to Rs.8.2 Cr, maiden Rs.600 Cr QIP oversubscribed 6.5x, CRISIL outlook upgraded to A-/Stable from Negative, plus an additional Rs.152 Cr insurance claim accepted
- IOL Chemicals ↓ (BULLISH)▲
Q2 revenue +40.1% YoY to Rs.795 Cr with EBITDA +79.6% and PAT +116.8% to Rs.65 Cr; EBITDA margin expanded 330 bps to 14.4% and H1 EPS nearly doubled to Rs.4.41 from Rs.2.18, funding a Rs.495 Cr three-project capex program
- Aarti Industries ↓ (BULLISH)▲
Revenue +73% YoY and +48% QoQ with EBITDA +60% YoY, capacity utilisation above 85% for major product groups, and a new 10+ year ~Rs.1,500 Cr (~US$150 Mn) global speciality chemical supply agreement
- Medi Assist Healthcare ↓ (BULLISH)▲
H1 FY27 PAT +60.2% YoY to Rs.49.2 Cr with EBITDA margin up 103 bps to 20.3%, zero debt, Rs.886.8 Cr net worth, and a Board-approved buyback of ~Rs.49.3 Cr at Rs.425/share
- Sugs Lloyd ↓ (BULLISH)▲
Q2 revenue more than doubled (+112% YoY) to Rs.134.9 Cr and PAT +108% to Rs.12.5 Cr on deferred Patna billing; order book of Rs.1,067 Cr equals 3.5x FY26 revenue after Rs.395 Cr of Q2 wins
- Schaeffler India ↓ (MIXED)▲
Revenue +27.4% YoY to Rs.30,058 Mn and +12.1% QoQ with all four divisions growing (Automotive +34.9%, VLS +22.0%, Bearings +14.7%, Exports +46.3%) — but PAT grew only 12.3% and FCF collapsed 81.7% to Rs.408 Mn
- Aditya Vision ↓ (MIXED)▲
Q2 FY27 revenue +28% YoY to Rs.586 Cr from Rs.458 Cr, though total expenses rose to Rs.564 Cr and finance costs climbed to Rs.22 Cr in H1 from Rs.19 Cr
- Prataap Snacks ↓ (BULLISH)▲
Management targets a 4-5% EBITDA margin uplift via cost optimization and a greenfield Indore plant expected to add over 1.5% structural margin accretion within 15-18 months, with non-Rings revenue compounding 12% and Pellets up 2.5x in five years
- MOIL ↓ (NEUTRAL)▲
Manganese ore prices held flat for November 2026 across all Ferro, Chemical, SMGR and Fines grades, with EMD basic at Rs.1,80,000/PMT — a stable pricing stance after the October reset
Risk Flags (10)
- Schaeffler India↓ [HIGH RISK]▼
EBITDA margin compressed 150 bps YoY to 18.7% (from 20.2%) and 40 bps QoQ, PAT growth of 12.3% badly lagged 27.4% revenue growth, and free cash flow collapsed 81.7% YoY to Rs.408 Mn on inventory and overdue-driven working capital build
- Reliance Retail [HIGH RISK]▼
Revenue grew only 6.4% YoY while EBITDA fell ~10-11% and PAT dropped 24% to Rs.2,611 Cr; EBITDA margin at 7.8% is down 140 bps YoY, 500 unviable stores were shut and retail area shrank to 77.5 Mn sq ft — the weakest segment inside an otherwise record quarter
- Jio Platforms↓ [MEDIUM RISK]▼
ARPU of Rs.218.8 rose just 3.5% YoY and the entire Rs.7 increase came from subscriber mix, not tariffs, with no tariff hike in almost two-and-a-half years and management declining to commit to timing; the international business has zero customers and zero revenue
- Aarti Industries↓ [MEDIUM RISK]▼
Consolidated EBITDA of Rs.418 Cr trailed standalone EBITDA of Rs.459 Cr due to an incremental stock-reserve provision on in-transit inventories, while working capital and debt rose on higher input prices, lifting finance costs; PDA utilisation remains depressed on weak US demand and China competition
- Neogen Chemicals↓ [MEDIUM RISK]▼
Consolidated PAT of Rs.8.2 Cr badly lagged standalone PAT of Rs.21.1 Cr as the Neogen Ionics ramp absorbed fixed costs and consolidated interest jumped 43% YoY to Rs.27.8 Cr; total NIL project cost is Rs.1,795 Cr with Dahej Phase 1 and Pakhajan Phase 2 both due Feb-Mar 2027
- Sugs Lloyd↓ [MEDIUM RISK]▼
Gross debt rose Rs.94 Cr in H1 to Rs.163 Cr, lifting debt/equity to 1.04x from 0.50x at March 2026; cost of materials jumped to 65.1% of revenue from 55.3% and Q2 EBITDA margin fell 158 bps YoY to 14.1%, while EPS growth of 63.3% lagged PAT growth of 108% due to IPO dilution
- Juniper Green Energy↓ [MEDIUM RISK]▼
Despite the turnaround, Net Debt stands at Rs.11,607 Cr with Net Debt/Net Worth at 2.22x, Q2 PAT was essentially flat QoQ (Rs.54 Cr vs Rs.53 Cr) and plant availability slipped to 98.7% from 99.1%
- Quality Power↓ [MEDIUM RISK]▼
Gross margin slipped 160 bps QoQ to 45.6% from 47.2%, LTM ROE fell to 26.6% in H1 FY27 from 35.4% in FY26 and 29.2% in FY25, and the order book grew only 3.3% QoQ to Rs.2,010 Cr — decelerating momentum beneath the headline beat
- IOL Chemicals↓ [MEDIUM RISK]▼
QoQ momentum stalled with Q2 revenue up only 5.1%, EBITDA +2.8% and PAT +0.9%; H1 operating cash flow fell to Rs.8.3 Cr from Rs.11.1 Cr and cash dropped to Rs.9.2 Cr from Rs.65.3 Cr at March 2026, even as Rs.495 Cr of capex is planned
- Medi Assist Healthcare↓ [MEDIUM RISK]▼
Retail TPA revenue declined 1.8% YoY to Rs.45.5 Cr with premiums managed down 8.5% to Rs.1,164 Cr, Retail share fell 331 bps YoY to 34.1%, Mayfair international grew only 1.1% YoY, and group retention eased to 90.5% with normalization expected over 3-4 quarters
Opportunities (10)
- Aarti Industries↓ (OPPORTUNITY)◆
The ~Rs.1,500 Cr (~US$150 Mn) 10+ year supply agreement with a global speciality chemical company is a multi-year revenue annuity, and PDA utilisation is guided to improve in Q3 FY27 as US demand recovers — a potential re-rating catalyst if the Q3 print confirms the turn
- Medi Assist Healthcare↓ (OPPORTUNITY)◆
Buyback at Rs.425/share for up to 11,59,199 shares (~Rs.49.3 Cr) from a zero-debt, Rs.886.8 Cr net-worth balance sheet, with EBITDA margin having recovered 330 bps in four quarters from the Q1 FY26 low of 17.1% and technology revenue up 83.8% to Rs.18.1 Cr
- Prataap Snacks↓ (OPPORTUNITY)◆
The Rings drag is now largely in the base (share down to ~10% from ~40% in FY21), so headline growth should converge toward the 12% non-Rings compounding rate, with a 4-5% EBITDA margin uplift program and Indore greenfield adding 1.5%+ structural accretion within 15-18 months
- Juniper Green Energy↓ (OPPORTUNITY)◆
ICRA upgrade to AA- (Stable)/A1+ plus 1,036 MWp and 503 MWh commissioned in FY27 to date should lower the 8.46% weighted average cost of debt on the operational portfolio, improving the interest-coverage trajectory as capacity monetizes
- Neogen Chemicals↓ (OPPORTUNITY)◆
Battery chemicals capacity ramp — 200 MTPA commissioned with first approval material shipped, another 1,000 MTPA commissioned in Q2, and 1,000 MT plus 500 MT intermediates due in H2 FY27 — sets up a FY28 earnings inflection as Ionics fixed costs get absorbed
- IOL Chemicals↓ (OPPORTUNITY)◆
Three-project Rs.495 Cr capex program (Ibuprofen expansion Rs.350 Cr, formulations CDMO Rs.110 Cr, specialty chemicals tolling Rs.35 Cr) targets higher-value downstream products, with Q2 EBITDA margin already up 330 bps YoY to 14.4%
- Quality Power↓ (OPPORTUNITY)◆
New Sangli Global Coil Factory and Turkey PCS manufacturing expand geographic reach, and the pending Rs.272.34 Cr WinWin Speciality acquisition could add scale — completion is the key near-term catalyst
- Sugs Lloyd↓ (OPPORTUNITY)◆
Order book of Rs.1,067 Cr at 3.5x FY26 revenue provides multi-year visibility, and finance cost fell to 2.5% of revenue from 3.8% YoY, partially offsetting the material-mix margin drag
- Aditya Vision↓ (OPPORTUNITY)◆
28% YoY Q2 revenue growth to Rs.586 Cr shows the store-expansion model still compounding despite expense growth to Rs.564 Cr — margin leverage is the swing factor to watch
- Reliance Industries↓ (OPPORTUNITY)◆
Jio's 542.4 Mn subscribers, 300 Mn 5G base and 30 Mn broadband homes with ARPU at Rs.218.8 and no tariff hike in 2.5 years leaves substantial latent pricing power — any tariff action would drop straight to EBITDA
Sector Themes (6)
- Growth Without Earnings Quality◆
Across the ten Q2 reporters, revenue growth was strong (median high-20s to low-30s YoY) but earnings quality diverged sharply — Schaeffler PAT +12.3% vs revenue +27.4%, Sugs Lloyd PAT +108% but EBITDA margin -158 bps, Quality Power gross margin -160 bps QoQ, and IOL QoQ PAT up just 0.9% — suggesting input-cost pass-through is inflating toplines without commensurate margin capture
- Working Capital and Debt Build◆
At least four companies flagged working capital or leverage deterioration — Schaeffler FCF -81.7% YoY on inventories and overdues, Aarti debt and finance costs up on higher input prices, Sugs Lloyd debt/equity doubling to 1.04x, and Juniper Green at 2.22x Net Debt/Net Worth — a cross-sector cash-conversion warning for H2 FY27
- Capital Returns and Balance Sheet Repair◆
Medi Assist's ~Rs.49.3 Cr buyback at Rs.425/share from a zero-debt balance sheet, Neogen's 6.5x oversubscribed Rs.600 Cr QIP with a CRISIL outlook upgrade, and Juniper Green's ICRA upgrade to AA-/A1+ show capital markets are rewarding deleveraging and clean balance sheets even as capex-heavy names (Neogen Rs.1,795 Cr NIL, IOL Rs.495 Cr) lean on external funding
- Back-Ended Guidance and FY29 Visibility◆
Forward commitments are large but distant — Aarti's ~Rs.1,500 Cr agreement commences FY29, Neogen's Dahej Phase 1 (Feb 2027) and Pakhajan Phase 2 (Mar 2027), Prataap's 15-18 month Indore margin accretion, and Quality Power's pending WinWin acquisition — meaning near-term earnings must be carried by existing operations
- Energy and Commodity Price Tailwinds◆
Reliance's O2C EBITDA +68-69% YoY on exceptionally tight energy markets and Aarti's input-price pass-through contrast with MOIL holding manganese ore prices flat for November 2026 — commodity-linked earnings are the biggest swing factor in the batch, with MOIL's flat pricing signaling stabilization rather than momentum
- Telecom Pricing Power in Waiting◆
Jio's ARPU of Rs.218.8 (+3.5% YoY) came entirely from subscriber mix with no tariff hike in almost two-and-a-half years, while 5G net adds were 15 Mn QoQ and 66 Mn YoY — the sector is accumulating unmonetized pricing capacity that represents a step-change earnings lever whenever tariffs move
Watch List (8)
- Super Spinning Mills, Thirumalai Chemicals, Banas Finance👁
All three report Q2 FY27 results on November 5, 2026, with trading windows closed — a clustered small/mid-cap earnings day to watch for guidance and any pre-result positioning
-
PDA capacity utilisation guided to improve in Q3 FY27 after US demand weakness and China competition — watch the Q3 print for confirmation of the turn and for any further stock-reserve provisions on in-transit inventories
-
Dahej Phase 1 targeted for February 2027 and Pakhajan Phase 2 for March 2027; watch for commissioning slippage and for the interest-cost trajectory (consolidated interest +43% YoY to Rs.27.8 Cr) as the Rs.1,795 Cr NIL project ramps
-
Rs.272.34 Cr WinWin Speciality acquisition remains under completion — watch for closure terms and valuation, plus order book momentum after only 3.3% QoQ growth to Rs.2,010 Cr
-
Buyback at Rs.425/share for up to 11,59,199 shares and group retention at 90.5% with normalization expected over 3-4 quarters — watch the four remaining insurers going live on the technology stack in H2 FY27
-
No tariff hike in almost two-and-a-half years with management declining to commit to timing — any tariff action would be a direct ARPU and EBITDA catalyst; also watch Reliance Retail margin at 7.8% (-140 bps YoY) after 500 store closures
-
Net Debt of Rs.11,607 Cr at 2.22x Net Worth with Q2 PAT flat QoQ at Rs.54 Cr — watch for further capacity commissioning against the 8.46% cost of debt and whether the AA- upgrade translates into refinancing savings
-
Indore greenfield commissioning and the 4-5% EBITDA margin uplift program over 15-18 months — watch quarterly Rings vs non-Rings mix for evidence the drag has bottomed
Filing Analyses
(22)
01-11-2026
Power Grid Corporation of India Limited's Board approved the sale and transfer of its entire equity stake in wholly owned subsidiary Central Transmission Utility of India Limited (CTUIL) to Grid Controller of India Limited (GRID-INDIA). The purchase price comprises an initial payment of ₹73.46 crore — derived from a Net Asset Value of ₹76.85 crore as on the 30th September, 2026 valuation date, adjusted for Specified Liability Deductions of ₹3.39 crore — plus a true-up amount to be determined for the period from the valuation date to closing, which must occur within 3 months of signing the Share Purchase Agreement.
- · Transaction follows an earlier letter dated 09th March, 2026
- · True-up amount to be determined based on valuation for the period from 30th September, 2026 to the closing date
- · Closing date must fall within 3 months from the date of signing of the Share Purchase Agreement (SPA)
- · CTUIL is a wholly owned subsidiary of POWERGRID
- · Disclosure made under Regulation 30 of SEBI (LODR) Regulations, 2015; SEBI Master Circular dated 30th January, 2026 details to be informed upon transaction completion
- · NSE Scrip ID: POWERGRID; BSE Scrip Code: 532898; ISIN: INE752E01010
01-11-2026
Aditya Vision Limited reported Q2 FY27 (quarter ended September 30, 2026) revenue from operations of ₹586 Cr versus ₹458 Cr in Q2 FY26, up ~28% YoY, while H1 FY27 revenue rose to ₹1,193 Cr from ₹1,779 Cr...
- · Total expenses rose to ₹564 Cr in Q2 FY27 from ₹443 Cr in Q2 FY26, and to ₹1,656 Cr in H1 FY27 from ₹1,312 Cr in H1 FY26
- · Finance costs increased to ₹22 Cr in H1 FY27 from ₹19 Cr in H1 FY26
- · Depreciation & amortisation rose to ₹26 Cr in H1 FY27 from ₹20 Cr in H1 FY26
- · Net cash from operating activities fell to ₹118 Cr in H1 FY27 from ₹136 Cr in H1 FY26
- · Net cash used in financing activities was ₹90 Cr in H1 FY27 versus ₹119 Cr in H1 FY26, including dividends paid of ₹16 Cr (vs ₹13 Cr) and borrowings repayment of ₹38 Cr (vs ₹77 Cr)
- · Cash and cash equivalents at end of period were ₹23 Cr (September 30, 2026) versus ₹19 Cr (September 30, 2025)
- · Exceptional item of ₹1 Cr in H1 FY26 related to impact of New labour code
- · Paid-up equity share capital ₹13 Cr (face value Re. 1 each)
- · Results reviewed by auditors under Regulation 33 of SEBI LODR; approved by Board on October 30, 2026
- · Company operates in a single primary segment (retail of electronic products); sales are seasonal and not comparable sequentially
01-11-2026
Prataap Snacks (DIAMONDYD) filed its Q2 & H1 FY27 earnings presentation on November 1, 2026, disclosing FY26 revenue of INR ~17.3 Bn (Rs. 1,725 Cr) and a 15-year revenue CAGR of 16%. The company flagged that Rings de-grew at a -9% CAGR from FY21 to FY26, dragging overall growth, while non-Rings revenue compounded at 12% and Rings' share of revenue fell to ~10% from ~40% in FY21. Management is targeting a 4-5% EBITDA margin uplift through cost optimization, supply chain, and plant efficiency initiatives, plus a greenfield Indore facility expected to deliver over 1.5% structural margin accretion within 15-18 months.
- · Rings category share of total revenue fell to ~10% in FY26 from ~40% in FY21
- · Rings category de-grew between 2021 and 2026, partly due to school closures during COVID
- · Pellets expanded 2.5x in 5 years; Namkeen business grown 2x in last 5 years
- · Namkeen currently present at ~7 lakh of PSL's ~25 lakh touchpoints
- · Target to grow emerging channels (Q-Commerce, Modern Trade, Exports) from less than 1% of revenue to more than 5% in three years
- · Greenfield Indore facility consolidates 7 smaller units; targeted readiness within 15-18 months
- · RLOP Foods acquisition closed Aug 2026; 100% equity stake acquired; merger with PSL to be initiated
- · Exports distribution in 7 countries
- · Manufacturing footprint: 13 facilities (6 owned, 7 third-party)
- · Revenue mix by geography FY26: North 31%, West 39%, East 24%, South 6%
01-11-2026
Schaeffler India's Q3 2026 revenue from operations grew 27.4% YoY to INR 30,058 mn (up 12.1% QoQ), with growth across all divisions: Automotive Technologies (+34.9%), Vehicle Lifetime Solutions (+22.0%), Bearings & Industrial Solutions (+14.7%) and Intercompany Exports & Others (+46.3%). However, earnings quality weakened — EBITDA margin declined to 18.7% from 20.2% in Q3'25 and 19.1% in Q2'26 on higher input costs and adverse fuel price effects, PAT rose only 12.3% YoY to INR 3,704 mn, and free cash flow collapsed 81.7% YoY to INR 408 mn amid working capital build-up from inventories and overdues.
- · 9M 2026 EBITDA margin fell to 19.0% from 19.7% in 9M 2025; EBIT margin declined to 15.8% from 16.2% and EBT margin to 16.8% from 17.3%
- · Bearings & Industrial Solutions grew only 3.6% in CY25 (INR 35,865 mn vs INR 34,625 mn) — the slowest of the three divisions
- · Working capital increase driven by inventories and overdues, remains a management focus area
- · Capex framework remains on track per management
- · Fifth plant opened at Shoolagiri, Tamil Nadu (est. 2025); e-axle line inaugurated at Talegaon, Pune
- · Savli plant adds 10,000+ sq. m. for spherical roller bearings; heat treatment facility commissioned at Maneja
- · Schaeffler India headcount rose from 2,922 (2021) to 3,826 (2025)
- · Schaeffler Group sales in 2025 were EUR 23.52 bn with ~110,800 employees and 104 plants globally
- · Ranked #1 in India and #7 globally in S&P Global Corporate Sustainability Assessment (CSA 76/100) in Machinery and Electrical Equipment sector; 100% renewable electricity across plants
- · Revenue mix CY25: Bearings & Industrial Solutions 39%, Automotive Technologies 34%, Exports & Others 15%, Vehicle Lifetime Solutions 12%
- · Global OEM nomination for transmission components; first e-axle delivered to a leading Indian OEM
01-11-2026
Aarti Industries' Q2 FY27 results presentation shows sharp growth: revenue up 73% YoY and 48% QoQ, EBITDA up 60% YoY and 9% QoQ, and PAT up 44% YoY and 9% QoQ, driven by overall volume growth and pass-through of elevated input prices. However, consolidated EBITDA of ₹418 cr trailed standalone EBITDA of ₹459 cr due to an incremental stock-reserve provision on in-transit inventories, and working capital and debt rose on higher input prices, lifting finance costs. The company also announced a 10+ year strategic manufacturing and supply agreement with a global speciality chemical company worth ~₹1,500 crore (~US$150 million) cumulative revenue, with operations expected to commence in FY29.
- · Capacity utilisation: >85% for major product groups, 65-85% for others, <65% for some groups
- · PDA capacity utilisation impacted by subdued US demand and competition from China; expected to improve in Q3 FY27
- · Polymer & Additives segment (10% revenue share) impacted by PDA chain softness
- · Agrochemicals & Fertilizers (12% share): weak monsoon and El-Nino risk could impact H2
- · Energy Application is largest end-use at 50% revenue share (16% domestic / 84% exports)
- · Pharma Applications 13% share; Dyes, Pigments & Printing Inks 12% share
- · Fluoro margins continue to remain under pressure
- · Acids value chain margins impacted by high sulfur prices
- · Plastics recycling JV project expected to be commissioned in H2 FY27
- · Augene JV under commissioning trial and ramp-up from H2 FY27
- · Target Debt/EBITDA of <2.5x
- · Zone IV projects to commercialise in FY27 and ramp up over next 18-24 months
- · Customer-led CAPEX financing of less than US$25 million for new supply agreement
01-11-2026
NHPC Limited disclosed a change in Senior Management Personnel under Regulation 30 of SEBI LODR Regulations, 2015. Shri Rajesh Kumar has been appointed as Executive Director (ED) through promotion, effective November 01, 2026. He holds a B.Sc. Engineering (Civil) degree and an MBA in Operations, joined the company on 06-01-1999, and has 27 years of service with NHPC.
- · Appointment effective date: November 01, 2026
- · Date of joining NHPC: 06-01-1999
- · Educational qualifications: B.Sc. Engineering (Civil), MBA in Operations
- · Designation is one level below the Board of Directors
- · Filing reference number: NH/CS/199
- · Scrip Code: 533098 (BSE), Symbol: NHPC (NSE); ISIN: INE848E01016
- · Filing digitally signed by Rupa Deb, Company Secretary, on 2026.11.01 at 21:55:25 +05'30'
01-11-2026
MOIL Limited disclosed that it has kept manganese ore prices unchanged for November 2026, effective from midnight of 31.10.2026/01.11.2026, continuing the levels prevailing since 01.10.2026. All Ferro grades (both Mn-44% and above and below Mn-44%), Chemical grades, SMGR grades and Fines were held flat, while EMD basic price remained at Rs.1,80,000/- PMT and EMD flakes at Rs.1,71,000/-. The filing reflects a flat month-on-month pricing stance with no increases or cuts across product categories.
- · Price revision effective from midnight of 31.10.2026/01.11.2026 for November 2026
- · Prices for all product categories were continued from levels prevailing since 01.10.2026
- · Disclosure made under Regulation 30 of SEBI (LODR) Regulations, 2015
- · NSE stock code: MOIL; BSE stock code: 533286
- · CIN: L99999MH1962GOI012398
01-11-2026
Medi Assist filed its Q2 and H1FY27 investor presentation, reporting H1FY27 total income of ₹492.4 Cr (+13.8% YoY), operating revenue of ₹478.0 Cr (+13.0% YoY), EBITDA of ₹97.2 Cr (+19.0% YoY) and reported PAT of ₹49.2 Cr (+60.2% YoY), with EBITDA margin at 20.3% (+103 bps YoY). Q2FY27 was weaker sequentially on growth: operating revenue rose just 3.9% YoY to ₹241.5 Cr and total income 4.5% to ₹245.4 Cr, while EBITDA grew 23.9% to ₹49.2 Cr and PAT jumped 167.5% to ₹21.6 Cr. However, the Retail TPA segment declined — revenue fell 1.8% YoY to ₹45.5 Cr and premiums managed dropped 8.5% to ₹1,164 Cr — and International revenue was nearly flat at +1.1% YoY in H1 (₹20.7 Cr), while Group retention eased to 90.5% with normalization expected over 3-4 quarters. The Board approved a share buyback of ~₹49.3 Cr at ₹425 per share for up to 11,59,199 shares, and the company remains zero-debt with net worth of ₹886.8 Cr.
- · Q2FY27 EBITDA margin 20.4% (+331 bps YoY); H1FY27 20.3% (+103 bps YoY)
- · EBITDA margin walk: recovered 330 bps in four quarters from Q1FY26 low of 17.1%
- · Retail share (TPA + platform) 34.1%, down 331 bps YoY; Retail share (TPA) 3.7%, down 162 bps YoY
- · Group retention 90.5%; company expects retention to normalize within 3-4 quarters
- · International revenue mix: Marine fell to 20.7% from 26.3% (-560 bps); Retail rose to 4.9% (+270 bps)
- · International annualised book of business +17% vs same months of FY26; 94% client retention; 14 corporate clients added
- · Technology revenue share 3.79% of H1FY27 revenue (+146 bps YoY); ~7 Mn total claims on MAtrix platform
- · MAven Guard: 85% of FWA savings AI-led; 200+ data points scored per claim
- · MAven IDP: 45%+ straight-through pre-authorizations; 10K+ claims/day; 99%+ within 15 minutes
- · Raksha Prime: 1.89 lakh bill-free, zero-wait discharges in H1FY26 (+21.2% YoY)
- · Government segment: 12.0% revenue share, 14 states and 4 UTs, 30.81 Cr lives
- · Capital allocation: plans to return ~50% of cumulative adjusted free cash flow over rolling five-year periods
- · Cash and cash equivalents ₹268.3 Cr vs ₹260.5 Cr in FY26; contract liability ₹321.7 Cr vs ₹280.2 Cr in FY26
- · Revenue per average headcount ₹13.7 Lakhs annualized vs ₹13.1 Lakhs in FY26
- · Zero debt position (Nil in FY26)
- · Group premiums grew 21.8% vs industry growth of 15.3%
- · 7 insurers contracted for technology; 3 live in H1FY27, 4 going live in H2FY27
01-11-2026
Juniper Green Energy reported a sharp Q2 FY27 turnaround with Total Income up 2.3x YoY to ₹372 Cr (Q2 FY26: ₹160 Cr) and PAT swinging to ₹54 Cr from ₹(18) Cr, while EBITDA rose 2.6x YoY to ₹340 Cr with margins expanding to 91% from 81%. H1 FY27 Total Income grew 2.0x YoY to ₹696 Cr and PAT jumped 32.4x to ₹106 Cr, though QoQ momentum was modest (Total Income +1.15x, PAT +1.02x) and leverage remains elevated with Net Debt of ₹11,607 Cr and Net Debt/Net Worth at 2.22x. Operational capacity reached 2,844 MWp plus 604 MWh BESS, with 1,036 MWp and 503 MWh commissioned in FY27 to date, and credit rating upgraded to AA- (Stable)/A1+ by ICRA.
- · Plant availability slipped marginally to 98.7% in H1 FY27 from 99.1% in H1 FY26, while grid availability was flat at 99.5% vs 99.4%
- · Q2 FY27 PAT growth was essentially flat QoQ at 1.02x (₹54 Cr vs ₹53 Cr in Q1 FY27)
- · Weighted average cost of debt for operational portfolio stands at 8.46% p.a.
- · Net Debt/Net Worth at 2.22x as on September 30, 2026
- · Days Receivable Outstanding rose to 25 days in H1 FY27 from 23 in FY26 and 17 in FY24
- · 98% of portfolio is with off-takers rated 'A' or above; 98% secured through long-term PPAs (typically 25 years)
- · Off-taker concentration: SJVN 24%, NHPC 22%, NTPC 16%, SECI 14%, GUVNL 11%, MSEDCL 10%, Tata Power 2%, Merchant 2%
- · PPA tariffs: SJVN FDRE 50 MW at INR 4.25/kWh; SECI FDRE RTC 230 MW at INR 5.26/kWh; GUVNL wind 50 MW at INR 3.51/kWh
- · Juniper Green Beam (50.4 MW wind) CUF 58.3% and Juniper Green Kite (72.45 MW wind) CUF 57.9% in H1 FY27
- · Credit rating upgraded to AA- (Stable)/A1+ by ICRA from A+ (Positive)/A1; 7 upgrades and 2 new ratings across 9 SPVs in FY27
- · Earnings conference call scheduled November 2, 2026 at 11:00 AM IST
01-11-2026
Super Spinning Mills Limited has intimated the stock exchanges that its Board of Directors will meet on Thursday, 5th November 2026 to consider and approve the Unaudited Financial Results for the quarter ended 30th September 2026. The company also confirmed that its trading window has been closed since 1st October 2026 and will remain closed until 48 hours after the Board meeting, in compliance with SEBI insider trading regulations.
- · Board meeting scheduled for Thursday, 5th November 2026 to approve Q2 FY27 (quarter ended 30th September 2026) unaudited financial results.
- · Trading window closed with effect from 1st October 2026 and will reopen 48 hours after the Board meeting.
- · Trading window closure was intimated to the stock exchanges on 29th September 2026.
- · BSE scrip code: 521180; NSE symbol: SUPERSPIN.
- · Company CIN: L17111TZ1962PLC001200.
02-11-2026
Reliance Industries reported its highest-ever consolidated EBITDA of Rs.62,409 Crore (up 24% YoY) and PAT of close to Rs.30,000 Crore (up 34% YoY) for Q2 FY27, driven by O2C EBITDA of Rs.25,203 Crore (up 68-69% YoY) on exceptionally tight energy markets. However, performance was mixed: Reliance Retail revenue grew only 6.4% YoY while EBITDA fell ~10-11% YoY (PAT down 24% to Rs. 2,611 crore) due to planned digital-commerce investment, and Oil & Gas EBITDA was ~2% lower. Jio Platforms delivered revenue of Rs.40,475 Crore (+11.4% YoY) and EBITDA of 21,879 Crore (+16.6% YoY), with the Jio IPO listing at a 26.7% premium making it India's second most valuable company.
- · Reliance Retail shut down 500 unviable stores while opening 303 new ones, net adds 200 lower; retail area fell to 77.5 million sq ft
- · Reliance Retail EBITDA margin at 7.8%, down 140 bps YoY and 10 bps QoQ
- · Jio ARPU at Rs.218.8, up 3.5% YoY without any tariff increase; data consumption 44.2 GB/user/month
- · JioHotstar MAU at 440 million vs 400 million YoY (+10%); launched in UK, Canada and Singapore
- · Gasoline cracks ~3x YoY, diesel ~3.5x, jet ~3.7x; gasoline crack near $25/bbl vs $8.4 prior year Q2
- · Brent ranged 70 to 130; refinery outages peaked at 11.8 million bpd, currently 4-5 million bpd
- · Ethane-naphtha cracking differential widened to $557, up 2.3x YoY
- · Naphtha flows from Middle East dropped from ~12.5 million tonnes to 6.5 million tonnes in the quarter
- · Global cracker utilization fell from 81% to 71%; Middle East operating rates fell from 80% to 50%
- · KG-D6 production at about 25 million standard cubic meters; deepwater rig returned for workovers
- · New Energy: module capacity 6+ GW targeting 20 GW early next year; solar cell ~5 GW targeting 20 GW in H1 next year; BESS 40 GWh in next half year; cell 35-40 GWh late next year
- · Data center capex: 44 MW in process over next 4-6 months, planning another 120 MW
- · Polymer demand down 3% domestically on supply constraints; PVC to EDC delta down 19%
01-11-2026
Quality Power Electrical Equipments reported strong Q2 FY27 consolidated performance with Total Income up 34.1% YoY to Rs. 285.45 Cr and PAT up 80.1% YoY to Rs. 63.33 Cr, while H1 FY27 Total Income rose 33.2% YoY to Rs. 550 Cr and PAT grew 52.4% to Rs. 110.05 Cr. EBITDA margin expanded to 28.6% in Q2 FY27 from 22.5% a year earlier, though gross margin slipped to 45.6% in Q2 FY27 from 47.2% in Q1 FY27. The company highlighted an order book of approximately Rs. 2,010 Cr, commencement of new Global Coil Factory in Sangli and PCS manufacturing in Turkey, and the pending WinWin Speciality acquisition (Rs. 272.34 Cr) that remains under completion.
- · Gross margin declined to 45.6% in Q2 FY27 from 47.2% in Q1 FY27, a 1.6 percentage point sequential contraction
- · Return on Equity on LTM basis fell to 26.6% in H1 FY27 from 35.4% in FY26 and 29.2% in FY25
- · Order book grew only 3.3% QoQ from Rs. 1,946 Cr in Q1 FY27 to Rs. 2,010 Cr in Q2 FY27
- · Net debt position remains net cash of Rs. 111 Cr in H1 FY27, down from Rs. 213 Cr in FY26
- · Working capital turnover deteriorated to 0.4x in H1 FY27 from 1.1x in FY25 and 0.8x in FY26
- · Debtor turnover declined to 3.1x in H1 FY27 from 5.0x in FY25
- · Inventory turnover declined to 3.1x in H1 FY27 from 4.7x in FY25
- · Endoks contributed 41% of Q2 FY27 Total Income and 47% of PAT; Mehru 33% of income and 19% of PAT
- · WinWin Speciality acquisition (Rs. 272.34 Cr) remains under completion
- · Endoks Turkey facility has approximately 4GW capacity and has already bagged close to 1GW in orders
- · Company completed type testing for porcelain insulators up to 400 kV and secured orders for 800 kV HVDC, 765 kV and 400 kV applications
- · Mehru existing capacity substantially committed; evaluating options to at least double manufacturing capacity
01-11-2026
Sugs Lloyd filed its Q2/H1 FY27 investor presentation, with Q2 revenue more than doubling 112% YoY to ₹134.9 Cr and PAT up 108% YoY to ₹12.5 Cr, driven by deferred Patna project billing. H1 FY27 revenue rose 73% to ₹213.3 Cr with PAT up 69% to ₹20.0 Cr, but EBITDA margin slipped 81 bps to 14.5% on a heavier material mix, and Q2 EBITDA margin fell 158 bps YoY to 14.1%. Order book stood at ₹1,067 Cr (3.5x FY26 revenue) after ₹395 Cr of Q2 wins, while gross debt rose ₹94 Cr in H1 to ₹163 Cr, lifting debt/equity to 1.04x from 0.50x at March 2026.
- · Q2 FY27 EPS ₹5.39 vs ₹3.30 YoY, growth of 63.3% lagged PAT growth due to IPO dilution
- · Cost of materials rose to 65.1% of revenue in Q2 FY27 from 55.3% a year ago
- · Finance cost fell to 2.5% of revenue in Q2 FY27 from 3.8% in Q2 FY26
- · H1 FY27 revenue of ₹213.3 Cr is already 71% of FY26 full-year revenue of ₹300.7 Cr
- · T&D and smart grid was 92% of Q2 FY27 revenue versus 46% in FY26; Solar EPC fell 68% QoQ to ₹10.2 Cr
- · Gross borrowings rose ₹94.1 Cr in H1, mostly short-term; debt/equity at 1.04x versus 1.1-1.2x ceiling
- · Net debt/EBITDA (annualised) rose to 2.6x from 1.6x in FY26
- · Return on equity (H1 annualised) declined to 27.2% from 33.0% in FY26
- · Interest cover improved to 5.2x from 4.8x in H1 FY26
- · Q2 book-to-bill was 2.9x; order book/revenue 2.7x for twelve months to Sep 2026
- · Company has no equity raise planned in FY27 or FY28
- · Earnings conference call scheduled November 03, 2026
01-11-2026
Thirumalai Chemicals Limited has notified the National Stock Exchange and BSE that its Board of Directors will meet on Thursday, November 05, 2026, to consider the Un-Audited Financial Results for the quarter and half year ended September 30, 2026. The intimation is a routine disclosure under Regulation 29 of the SEBI Listing Regulations and contains no financial figures or performance data.
- · Board meeting scheduled for Thursday, November 05, 2026
- · Results to be considered cover the quarter and half year ended September 30, 2026
- · Filing reference number: TCL/SE051/2026-27
- · Scrip codes: TIRUMALCHM (NSE) and 500412 (BSE)
- · Company CIN: L24100MH1972PLC016149
- · Registered office: Thirumalai House, Plot No. 101-102, Road No. 29, Sion (East), Mumbai – 400 022
- · Company holds ISO 9001, 14001, 50001, HACCP and FSSC 22000 certifications
01-11-2026
Neogen Chemicals reported strong Q2 FY27 consolidated revenue of ₹296 crore (+42% YoY from ₹208.7 crore) and standalone revenue of ₹288 crore (+39% YoY), with consolidated EBITDA up 51% to ₹45.3 crore and standalone EBITDA up 54% to ₹53.7 crore. However, consolidated PAT of ₹8.2 crore (+144% YoY) lagged standalone PAT of ₹21.1 crore (+127% YoY), reflecting initial fixed-cost absorption at the ramping Neogen Ionics battery chemicals unit and higher interest costs (consolidated interest +43% YoY to ₹27.8 crore). The company completed a maiden ₹600 crore QIP oversubscribed 6.5x, received an additional ₹152 crore insurance claim acceptance, and approved Organolithium capacity expansion from 300 to 600 MTPA at up to ₹45 crore investment.
- · CRISIL revised long-term rating outlook to 'CRISIL A-/Stable' from 'Negative'; short-term ratings reaffirmed at 'CRISIL A2+'.
- · Consolidated total assets rose to ₹4,005 crore (Sep 30, 2026) from ₹2,302 crore (Sep 30, 2025); shareholders' funds increased to ₹1,578 crore from ₹800 crore.
- · Dahej Phase 1 target completion February 2027; Pakhajan Phase 2 completion expected March 2027.
- · Electrolyte mechanical assembly complete with trial runs begun; electrolyte recipes received from 5–6 giga factories.
- · Lithium Electrolyte Salts: provisional approvals from 5 major international customers; final site audits completed for 3 US-based electrolyte manufacturers; commercial supply commenced with 2 customers.
- · 200 MTPA commissioned and first approval material shipped; another 1,000 MTPA commissioned in Q2 FY27; remaining 300 MTPA trial production ongoing; 1,000 MT and 500 MT intermediate to be commissioned in H2 FY27.
- · Standalone EPS Q2 FY27 ₹7.60 vs ₹3.53; consolidated EPS ₹2.96 vs ₹1.28.
- · H1 FY27 standalone revenue ₹540.3 crore (+38% YoY) and PAT ₹40.6 crore (+72% YoY).
01-11-2026
Jio Platforms held its first analyst meet as a listed company, reporting Q2 FY2026-27 revenue from operations of ₹40,475 Crore (up 11.4% YoY) and EBITDA of ₹21,879 Crore (up 16.6% YoY, 54.1% margin), with PAT up 13.7% YoY to ₹8,387 crore. Growth was driven by 542.4 million total subscribers (36 million YoY net adds), a 300 million 5G base, 30 million broadband homes and ARPU of ₹218.8 (up 3.5% YoY). However, ARPU growth of 3.5% was modest and driven purely by subscriber mix rather than tariff hikes, with management noting no tariff action for almost two-and-a-half years, while the international business currently has zero customers and zero revenue.
- · ARPU rose from ₹211.4 to ₹218.8, with the ₹7 increase attributed purely to better subscriber mix, not tariff hikes
- · No tariff hike for almost two-and-a-half years; management declined to commit to timing
- · 5G net adds were 15 million QoQ and 66 million YoY
- · Jio holds 51% CMS in wireless broadband and 60% of the 5G subscriber base
- · Fixed wireless access is ~50% of the fixed broadband base
- · Net leverage at 0.11x; company is net debt positive post-IPO proceeds
- · ROCE improved 80 bps to 11% in the quarter
- · International business currently has zero customers and zero revenue; targeting 10-15 partnerships
- · Gemini free period was signed for 18 months, with less than 12 months elapsed
- · FY2026 full-year EBITDA exceeded $8 billion
01-11-2026
Neogen Chemicals reported Q2 FY27 consolidated revenue of INR 296 crore, up 42% Y-o-Y, with EBITDA at INR 45 crore (+51% Y-o-Y) and PAT at INR 8 crore (+144% Y-o-Y), driven by volume growth and a ramp-up in Neogen Ionics (revenue INR 37 crore vs INR 5.4 crore in Q2 FY26). However, profitability remained thin as PAT was dampened by higher interest and depreciation from ongoing CAPEX, elevated feedstock costs, Dahej plant rebuild and initial fixed-cost absorption at NIL. The company completed a maiden INR 600 crore QIP (oversubscribed 6.5x), received a CRISIL outlook upgrade to 'CRISIL A-/Stable', and accepted an additional INR 152 crore insurance claim for the Dahej fire, while total NIL battery-materials project cost stands at INR 1,795 crore.
- · Consolidated EPS for Q2 FY27 stood at INR 2.96 per share (not annualized)
- · Dahej Phase 1 project cost INR 428 crore with target completion by February 2027; Pakhajan Phase 2 budgeted at INR 1367 crore with completion expected by March 2027
- · Battery Chemicals capacity: 200 MTPA commissioned with first approval material shipped; another 1000 MTPA commissioned in Q2 FY27; remaining 300 MTPA trial production ongoing; 1000 MT and 500 MT intermediate to be commissioned in H2 FY27
- · Electrolyte recipes received from 5-6 giga factories with joint trials underway; provisional approvals from 5 major international customers and final site audits completed for 3 US-based electrolyte manufacturers; commercial supply commenced with 2 customers
- · PAT impacted temporarily by higher interest and depreciation costs from ongoing CAPEX; interest expenses expected to decline via term debt reduction using QIP proceeds
- · CRISIL revised long-term rating outlook to 'CRISIL A-/Stable' from 'Negative'; short-term ratings reaffirmed at 'CRISIL A2+'
- · Company operates four manufacturing facilities (Mahape, Dahej SEZ, Karakhadi, Patancheru) with a product portfolio of over 313 products
01-11-2026
Medi Assist reported H1 FY27 operating revenue growth of 13.0% YoY to ₹478.0 Cr, with EBITDA up 19.0% to ₹97.2 Cr and margins expanding 103 bps to 20.3%. PAT surged 59.5% YoY, driven by technology revenue (+83.8% to ₹18.1 Cr) and Paramount integration. However, Mayfair international revenue grew only 1.1% YoY to ₹20.7 Cr, and the company announced a buyback of up to ~₹49.3 Cr.
- · Mayfair We Care revenue grew only 1.1% YoY in H1 FY27 to ₹20.7 Cr, and 7.7% in Q2 FY27 to ₹10.7 Cr.
- · Client retention rate stood at 90.5%.
- · Three of seven contracted insurers are fully live on the technology stack, with the remaining four scheduled for H2 FY27.
- · The buyback of up to ~₹49.3 Cr will use less than a fifth of accumulated cash reserves.
- · Platform premiums reached ₹9,648 Cr in H1 FY27.
- · Group premiums under management grew 21.8% YoY to ₹13,939 Cr, outpacing industry growth by 650 bps.
01-11-2026
Gujarat Energy Limited (erstwhile Gujarat Gas Limited) disclosed via Regulation 30 that it has appointed Ernst & Young LLP as its Investor Relations agency and Veritas Reputation as its Public Relations agency, aimed at strengthening investor engagement and media communication. The filing contains no financial figures, no shareholding changes, and confirms both parties are unrelated to the promoter group with no related-party transaction implications. This is a routine administrative disclosure with no impact on financials or operations.
- · BSE Company Code: 539336; NSE Symbol: GUJENERGY
- · CIN: L40200GJ2012SGC069118
- · Registered office: Gujarat Energy Bhavan, Sector-11, Gandhinagar, Gujarat – 382010
- · Corporate office: IT Tower-2, Infocity, Gandhinagar – 382009
- · Disclosure references SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026
- · No shareholding by EY or Veritas Reputation in the company (Nil)
- · No special rights, no related-party transaction, no promoter/promoter group relationship
- · Filing signed by Sandeep Dave, Company Secretary, dated 1st November, 2026
01-11-2026
Banas Finance Limited has scheduled a Board Meeting on November 5, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for Q2 and H1 FY27 (quarter and half year ended September 30, 2026). The trading window for designated persons is currently closed and will reopen 48 hours after the declaration of the unaudited standalone financial results. No financial figures were disclosed in this intimation.
- · Board Meeting date: November 5, 2026
- · Financial results period: Q2 and H1 ended September 30, 2026
- · Trading window closed and will reopen 48 hours after declaration of unaudited standalone financial results
- · Scrip Code: 509053
- · Filing date: November 1, 2026
02-11-2026
Tejnaksh Healthcare Limited disclosed under Regulation 30 of SEBI LODR that its Managing Director, Dr. Ashish V. Rawandale-Patil, has been selected as a Mentor for the Endourological Society's Technology Innovation Program 2027 (ES-TIP 2027). He is the only urologist from outside the United States among the mentors, joining three distinguished mentors from leading US institutions. The filing contains no financial figures or period-over-period performance data, so no quantitative comparison is possible.
- · Scrip Code: 539428; Security ID: TEJNAKSH
- · Filing dated November 02, 2026 (signed 13:05:31 +05'30')
- · ES-TIP 2027 aims to support and mentor medical innovations and assist healthcare professionals in developing novel ideas, with promising innovations considered for further development and commercialization
- · No financial or operational metrics were disclosed in this filing
02-11-2026
IOL Chemicals and Pharmaceuticals reported Q2 FY27 standalone revenue from operations of ₹795.0 Cr (+40.1% YoY) with EBITDA of ₹114.9 Cr (+79.6% YoY) and PAT of ₹65.0 Cr (+116.8% YoY); H1 FY27 revenue reached ₹1551.3 Cr (+38.6% YoY) with EBITDA of ₹226.6 Cr (+69.7% YoY) and PAT of ₹129.5 Cr (+102.5% YoY). However, QoQ momentum was modest — Q2 revenue rose only 5.1% over Q1 FY27 (₹756.3 Cr), EBITDA grew just 2.8% and PAT 0.9%, while net cash from operating activities fell to ₹8.3 Cr in H1 FY27 from ₹11.1 Cr in H1 FY26 and cash and cash equivalents dropped to ₹9.2 Cr from ₹65.3 Cr at March 2026. The company outlined ₹495 Cr of planned investment across three strategic projects (Ibuprofen expansion ₹350 Cr, formulations CDMO ₹110 Cr, specialty chemicals tolling ₹35 Cr).
- · Q2 FY27 EBITDA margin improved to 14.4% from 11.1% YoY; PAT margin 8.1% vs 5.2%
- · H1 FY27 EBIT ₹183.1 Cr vs ₹93.8 Cr YoY (+95.3%); Q2 EBIT ₹92.7 Cr vs ₹44.0 Cr (+110.7%)
- · H1 FY27 EPS ₹4.41 vs ₹2.18; Q2 FY27 EPS ₹2.21 vs ₹1.02
- · Net cash from operating activities declined to ₹8.3 Cr in H1 FY27 from ₹11.1 Cr in H1 FY26 despite higher profits
- · Cash and cash equivalents fell to ₹9.2 Cr (Sep 26) from ₹65.3 Cr (Mar 26); current borrowings rose to ₹194.2 Cr from ₹132.0 Cr
- · Capital work in progress increased to ₹189.4 Cr from ₹93.6 Cr, reflecting ongoing capex
- · Total equity rose to ₹1,925.5 Cr from ₹1,798.4 Cr; total assets ₹2,830.4 Cr vs ₹2,586.7 Cr
- · Geographical mix: 72% domestic, 28% exports
- · Non-Ibuprofen share of revenue rose to 44% in H1 FY27 from 18% in FY21
- · Ibuprofen expansion expected commercialization FY28; formulations CDMO FY27; tolling project FY27
- · Formulations CDMO received GMP Certificate of a Manufacturer from Hungary's National Centre for Public Health and Pharmacy
- · Projects to be funded through internal accruals
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 22 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Pre-Market Regulatory Roundup
🇮🇳 More from India
View all →November 02, 2026
India Upcoming Corporate Actions BSE NSE — November 02, 2026
India Upcoming Corporate Actions BSE NSE
November 02, 2026
India Quarterly Results BSE NSE Announcements — November 02, 2026
India Quarterly Results BSE NSE Announcements
November 01, 2026
India Quarterly Results BSE NSE Announcements — November 01, 2026
India Quarterly Results BSE NSE Announcements
November 01, 2026
India Stock Market Daily Regulatory Digest — November 01, 2026
India Stock Market Daily Regulatory Digest